Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Humana EPS shocker. Are Medicare Advantage plans in jeopardy?
Humana EPS shocker. Are Medicare Advantage plans in jeopardy?

Health insurance carrier Humana Inc. (NYSE: HUM) reported a bombshell when it released its fourth-quarter 2023 earnings report. The company not only missed its estimated EPS by a mile but also

5 top healthcare stocks for earnings growth in 2024
5 top healthcare stocks for earnings growth in 2024

While the healthcare sector delivered lackluster profit growth in 2023, it should change this year. 

Sector components forecast to show the biggest earnings year-over-year earnings improvement

UnitedHealth's rising premiums could cushion stubborn inflation
UnitedHealth's rising premiums could cushion stubborn inflation

When markets become uncertain about the economy's direction and stocks trend in a bumpy and indecisive pattern, some sectors usually attract investment dollars because of their perceived safety.

Medtronic receives FDA approval for deep brain stimulation system
Medtronic receives FDA approval for deep brain stimulation system

Medtronic PLC (NYSE: MDT), a member of the medical sector and the healthcare industry, received U.S. FDA approval for its implantable medical device called the Percept PC Deep Brain Stimulation

UnitedHealth's rising premiums could cushion stubborn inflation
UnitedHealth's rising premiums could cushion stubborn inflation

When markets become uncertain about the economy's direction and stocks trend in a bumpy and indecisive pattern, some sectors usually attract investment dollars because of their perceived safety.

Time to buy these 3 healthcare companies that raised revenue guidance?
Time to buy these 3 healthcare companies that raised revenue guidance?

The new year brings a clean slate heading into the fourth-quarter earnings season. Companies can usually gauge if their previous forecasts were in line or need to be adjusted to warn or prepare

Time to buy these 3 healthcare companies that raised revenue guidance?
Time to buy these 3 healthcare companies that raised revenue guidance?

The new year brings a clean slate heading into the fourth-quarter earnings season. Companies can usually gauge if their previous forecasts were in line or need to be adjusted to warn or prepare

UnitedHealth Group Looks Buyable After AI-Fueled Double Beat
UnitedHealth Group Looks Buyable After AI-Fueled Double Beat

The big banks will get the headlines, but investors should watch UnitedHealth Group Inc. (NYSE: UNH). The health insurance giant scored a double beat when it reported fourth-quarter earnings on

UnitedHealth Group Looks Buyable After AI-Fueled Double Beat
UnitedHealth Group Looks Buyable After AI-Fueled Double Beat

The big banks will get the headlines, but investors should watch UnitedHealth Group Inc. (NYSE: UNH). The health insurance giant scored a double beat when it reported fourth-quarter earnings on

HCA Healthcare Rallies: Weight-loss drugs really a big threat?
HCA Healthcare Rallies: Weight-loss drugs really a big threat?

Hospital chain HCA Healthcare, Inc. (NYSE: HCA) has been working on a bullish base and even managed to post gains in a week when the SPDR S&P 500 ETF Trust (NYSEARCA: SPY) pulled back. 

Investors

Mega merger in the works? Humana, Cigna explore big deal
Mega merger in the works? Humana, Cigna explore big deal

Consolidation in the health insurance industry has become a theme of 2023. Humana Inc. (NYSE: HUM) is reportedly in talks to merge with The Cigna Group (NYSE: CI) in a stock-and-cash deal

BellRing Brands gets pumped on the Ozempic weight-loss trend
BellRing Brands gets pumped on the Ozempic weight-loss trend

Sports nutritional products maker BellRing Brands Inc. (NYSE: BRBR) has seen its stock surge to new all-time highs driven by the popularity of GLP-1 weight-loss medication usage. While the name of

Medtronic: oversold, overextended high yield reversal in play
Medtronic: oversold, overextended high yield reversal in play

After two years of correction and downtrend, providing ample incentive to buyers all along the way, medical device maker Medtronic (NYSE: MDT) has finally reached its bottom, and the reversal is

J&J stock down as business unit mulls talc-related bankruptcy
J&J stock down as business unit mulls talc-related bankruptcy

Shares of Johnson & Johnson (NYSE: JNJ) slid 4.84% lower the week ending October 27, as the company’s subsidiary LTL Management is facing a raft of lawsuits pertaining to talc in its baby powder. 

J&J stock down as business unit mulls talc-related bankruptcy
J&J stock down as business unit mulls talc-related bankruptcy

Shares of Johnson & Johnson (NYSE: JNJ) slid 4.84% lower the week ending October 27, as the company’s subsidiary LTL Management is facing a raft of lawsuits pertaining to talc in its baby powder. 

The Value Deepens for Medtech Stocks: Reversal Imminent
The Value Deepens for Medtech Stocks: Reversal Imminent

Results from Johnson & Johnson (NYSE: JNJ) and Abbott Laboratories (NYSE: ABT) foreshadow good news for MedTech investors. Both companies outperformed on the top and bottom lines, driven by broad

Walgreens Boots Alliance: Value or Value Trap?
Walgreens Boots Alliance: Value or Value Trap?

Walgreens Boots Alliance (NASDAQ: WBA) shares are down significantly over the past two years and may fall further. The company's turnaround efforts are slowly taking hold, and the impact of

Healthcare Giant Outperforms: A Healthy Dose of Market Resilience
Healthcare Giant Outperforms: A Healthy Dose of Market Resilience

Over the last month, the overall market has experienced significant selling amid increased uncertainty. The S&P 500 ETF Trust (NYSE: SPY) has traded almost 5.5% lower in that period, and wherever

Healthcare Giant Outperforms: A Healthy Dose of Market Resilience
Healthcare Giant Outperforms: A Healthy Dose of Market Resilience

Over the last month, the overall market has experienced significant selling amid increased uncertainty. The S&P 500 ETF Trust (NYSE: SPY) has traded almost 5.5% lower in that period, and wherever

3 Undervalued Healthcare Stocks to Watch as Sector Struggles
3 Undervalued Healthcare Stocks to Watch as Sector Struggles

The Health Care Select Sector SPDR Fund (NYSEARCA: XLV) is down 2.40% in the past three months, and down 4.67% year-to-date. 

With the current sector-wide downturn, it’s not surprising that

3 Undervalued Healthcare Stocks to Watch as Sector Struggles
3 Undervalued Healthcare Stocks to Watch as Sector Struggles

The Health Care Select Sector SPDR Fund (NYSEARCA: XLV) is down 2.40% in the past three months, and down 4.67% year-to-date. 

With the current sector-wide downturn, it’s not surprising that

3 Undervalued Healthcare Stocks to Watch as Sector Struggles
3 Undervalued Healthcare Stocks to Watch as Sector Struggles

The Health Care Select Sector SPDR Fund (NYSEARCA: XLV) is down 2.40% in the past three months, and down 4.67% year-to-date. 

With the current sector-wide downturn, it’s not surprising that

Are the S&P 500's Biggest Q3 Losers Next Year's Winners?
Are the S&P 500's Biggest Q3 Losers Next Year's Winners?

What started out to be a promising third quarter for U.S. stocks turned into a dud. On the backs of artificial intelligence (AI) excitement, the S&P 500 stormed out of the gates in July only to

Can Undervalued Healthcare Stocks Add Yield To Your Portfolio?
Can Undervalued Healthcare Stocks Add Yield To Your Portfolio?

If you had to guess the largest S&P company outside of big tech stocks or Berkshire Hathaway Inc. (NYSE: BRK.B), would you guess a healthcare stock

Health insurer UnitedHealth Group Inc. (NYSE:

3 Takeaways from the August Inflation Report
3 Takeaways from the August Inflation Report

The market advanced following the August PCE price index report, but investors and traders should not discount the news. The PCE index remains cool relative to the peaks of the inflation scare,